Figure 3From: Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs – a systematic review and network meta-analysis Modeled change in pain, PGA, HAQ-DI and SF36 for different classes of biologic treatments with and without MTX. Back to article page